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wsh@hactcm.edu.cAbstract This study reports an investigation into the chemical constituents of the whole plant of
Selaginella moellendorfﬁi Hieron. Ten compounds, isolated and puriﬁed by column chromato-
graphy, were identiﬁed on the basis of spectral analysis and their physicochemical properties to be:
(8R)-3,5-dimethoxy-4-hydroxyphenylpropylalcohol-8-(1-acetyl-3-methoxy-4-hydroxyphenyl)-9-O-b-
D-glucopyranoside (moellenoside B) (1), amentoﬂavone (2), hinokiﬂavone (3), apigenin-7-O-b-
neohesperidoside (4), apigenin-8-C-b-D-glucopyranoside (5), adenosine (6), uridine (7), 2,3,4,
9-tetrahydro-1H-pyrido[3, 4-b]indole-3-carboxylic acid (8), vanillic acid (9), and lariciresinol (10).
Compound 1 is a new norlignan lignanoside and compounds 4–10 were isolated from this plant for
the ﬁrst time.
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Table 1 NMR data for compound 1 (CD3OD) (
1H
400 MHz; 13C 100 MHz) (J in Hz).
Position dH dC HMBC DEPT
1 134.2 C
2
6.31 (br s) 107.3
C-3, C-6,
C-7
CH
3 148.8 C
4 132.0 C
5 148.8 C
6 6.31 (br s) 107.3 C-2, C-7 CH
7 2.99 (dd,
13.8, 5.9)
39.4 C-2/6, C-10 CH2
2.78 (dd,
13.8, 5.9)
8 4.02 (m) 42.9 CH
9 3.82 (m);
3.74 (m)
66.2 C-100, C-10 CH2
3,5-OCH3 3.70 (s) 56.6 2CH3
10 134.9 C
20 7.44 (d, 1.8) 110.7 C-30, C-40 CH
30 153.7 C
40 149.6 C
50 139.3 C
60
7.53 (d, 1.8) 122.2
C-8, C-20,
C-40,
CH
C-70
70 199.9 C
80 2.57 (s) 26.6 C-10, C-70 CH3
30-OCH3 3.87 (s) 56.5 C-30 CH3
100 4.88 (d, 7.4) 104.8 C-9 CH
200 3.44 (m) 75.0 CH
300 3.35 (m) 77.8 CH
400 3.48 (m) 71.2 CH
500 3.13 (m) 78.1 CH
600 3.67 (m);
3.74 (m)
62.3 CH2
Compounds from Selaginella moellendorfﬁi Hieron 371. Introduction
Selaginella moellendorfﬁi Hieron (Selaginella Beauv.) is widely
distributed in Southeast Asia and China south of the Yangtze
river. It has been used as a folk remedy in the treatment of a
number of conditions including hepatitis and idiopathic
thrombocytopenic purpura1. A Chinese patent-medicine,
‘‘Jiangnanjuanbai tablet’’, has been produced from a plant
extract. However, to date, there have been few reports
concerning its active principles. We have previously reported
a new dihydrobenzofuran lignanoside of the plant2 and now
report the results of further phytochemical investigations
showing the presence of another new compound together with
nine known compounds, seven of which were isolated from
this plant for the ﬁrst time.
The compounds were identiﬁed as moellenoside B (1)
(Fig. 1), amentoﬂavone (2), hinokiﬂavone (3), apigenin-7-O-
b-neohesperidoside (4), apigenin-8-C-b-D-glucopyranoside (5),
adenosine (6), uridine (7), 2,3,4, 9-tetrahydro-1H-pyrido[3,4-b]
indole-3-carboxylic acid (8), vanillic acid (9) and lariciresinol
(10). The isolation and structural elucidation of these com-
pounds are described.
2. Results and discussion
Compound 1 was obtained as a white amorphous powder. Its
molecular formula was determined as C26H34O12 from the
presence in the positive HR-ESI-MS spectrum of a pseudo-
molecular ion [MþNa]þ at m/z 561.194 5 (calcd. for
C26H34O12Na, 561.194 7). The UV spectrum of 1 showed
absorption peaks at 207 and 280 nm. The IR spectrum showed
absorption bands at 3338, 2927, 2723, 2856, 1674, 1530, 1209,
1105 and 1064 cm1.
The 1H NMR spectrum (Table 1) showed two doublets at
dH 7.53 (1H, d, J¼1.8 Hz) and dH 7.44 (1H, d, J¼1.8 Hz) and
one broad singlet with two protons at dH 6.31 (2H, br s).
Based on the HSQC spectrum, the corresponding 13C NMR
peaks at dC 122.2, 110.7 and 107.3, respectively conﬁrm that
the dH 6.31 signal arises from two magnetically equivalent
protons. HSQC also showed dH 2.99 (1H, dd) and dH 2.78
(1H, dd) belong to dC 39.4, dH 4.02 (1H, m) belongs to dC 42.9
and dH 3.82 (1H, m) and dH 3.74 (1H, m) belong to dC 66.2.
These data and signals in the 1H–1H COSY spectrum reveal
the presence of a –CH2–CH–CH2–O– moiety. In addition,
the presence of two signals at dC 199.9 and dC 26.6 in the
13C NMR spectrum and one at dH 2.57 (3H, s) in the
1H NMR
spectrum are consistent with an acetyl group. The anomericFigure 1 Structure and key HMBC correlations (HyC) of
compound 1.proton signal of glucose at dH 4.88 (1H, d, J¼7.4 Hz), was
shown to arise from a b-glucose on the basis of its coupling
constant. Acid hydrolysis of 1 using 4 mol/L HCl yielded
D-glucose identiﬁed by comparison with an authentic sample
on TLC.
The HMBC spectrum showed cross signals between dH 6.31
(2H, br s) and dC 39.4 (C-7) and between dH 7.53 (1H, d,
J¼1.8 Hz) and dC 42.9 (C-8) suggesting that the –CH2–CH–
CH2–O– moiety links the A and B rings with dC 39.4 (C-7) and
dC 42.9 (C-8), respectively (Fig. 1). In addition, the linkage of
the glucosyl moiety to the aglycone was determined on the
basis of long-range correlation between dH 4.88 (1H, d,
J¼7.4 Hz) of glucose and dC 66.2 (C-9) of the aglycone.
Cross signals in HMBC between dH 2.57 (3H, s) and dC 134.9
(C-10) indicated that the acetyl group is linked directly to the B
ring. Cross signals also showed that the methoxy signal at dH
3.70 (6H, s) was linked to C-3 and C-5 and the methoxy signal
at 3.87 (3H, s) was linked to C-30.
The absolute conﬁguration of 1 was established as (R) on
the basis of the positive Cotton effect at 285 nm in its CD
spectrum and the ½a20D 36.7 (c 0.18, CHCl3). The aglycone
also showed a positive Cotton effect at 282 nm {½a20D 24.8
(c 0.11, CHCl3)} indicating that the glucosyl moiety has no
Figure 2 Structure of 1-deoxycarinatone.
Wei-sheng Feng et al.38effect on the optical rotation opticity of 1. The data for the
aglycone are opposite to that for the reported compound
1-deoxycarinatone3 (Fig. 2), which has the S-conﬁguration
[negative Cotton effect at 291 nm {½a20D þ33.3 (c 0.6, CHCl3)}].
Compound 1 was established as (8R)-3,5-dimethoxy-4-hydro-
xyphenyl-propylalcohol-8-(1-acetyl-3-methoxy-4-hydroxyphe-
nyl)-9-O-b-D-glucopyranoside4, named moellenoside B.
3. Experimental
3.1. Equipment and reagents
Chemical reagents were purchased from Beijing Chemical
Plant and Tianjin No. 3 Reagent Plant. Chromatographic
materials (suppliers) were as follows: Diaion HP-20 (Mitsu-
bishi Chemical Corp., Japan), silica gel (160–200 mesh,
Qingdao Haiyang Chemical Co., Ltd., China) and Toyopearl
HW-40C (TOSOH Corp., Japan). TLC was conducted on
silica gel G (Qingdao Haiyang Chemical Co., Ltd., China)
plates made in-house. Melting point was determined on a
Koﬂermicromelting point apparatus (uncorrected). Optical
rotation was measured using a Perkin Elmer 341 Polarimeter.
CD, UV and IR spectra were recorded on a Jasco J715
spectropolarimeter, Shimadzu UV–vis 2201 spectrophot-
ometer and Shimadzu FTIR-8201 PC spectrometer, respec-
tively. 1H and 13C NMR spectra were obtained on a Bruker
DPX-400 spectrometer (400 MHz for 1H NMR and 100 MHz
for 13C NMR) with TMS as internal standard. HR-ESI-MS
was recorded on an APEX II spectrometer. EI mass spectra
were taken on a JEOL JMS-GCMATE mass analyzer.
3.2. Plant material
The whole plants were collected in Xixia County, Henan
Province, P.R. China, and authenticated by Prof. Cheng-ming
Dong. A voucher specimen (No. 20060508) was deposited
in the herbarium of Henan College of TCM, Zhengzhou,
P.R. China.
3.3. Extraction and isolation
Whole plants (8 kg) were shade dried, chopped and extracted
twice with 70% aqueous acetone at room temperature. The
combined extract was concentrated under vacuum, diluted
with water and partitioned between ether, ethyl acetate and
n-BuOH. The ether layer (30 g) was chromatographed on a
silica gel column using a gradient system of CHCl3–MeOH as
an eluent to afford fractions A–E. Fraction C (5.6 g) was then
chromatographed repeatedly on a silica gel column eluted with
CHCl3–MeOH (8:1) to yield 2 (25 mg) and 3 (17 mg).The ethyl acetate layer (50 g) was chromatographed on a
silica gel column using a gradient system of EtOAc–EtOH–
H2O as an eluent to afford fractions A–C. Fraction B (8.2 g)
was passed through a silica gel column using CHCl3–MeOH–
H2O (5:1:0.1), to yield 6 (10 mg) and 4 (8 mg). Fraction C
(3.4 g) was passed through a silica gel column, using CHCl3–
MeOH–H2O (3:1:0.1), and further puriﬁed by repeated chro-
matography on a Toyopearl HW-40C column using MeOH as
an eluent to yield 7 (30 mg).
The n-BuOH layer (80 g) was chromatographed on a
Diaion HP-20 column with aqueous MeOH (0–70%). The
10%MeOH fraction was evaporated to dryness under reduced
pressure at 50 1C, redissolved in MeOH and puriﬁed by
repeated chromatography on a Toyopearl HW-40C column
using MeOH as an eluent to yield 1 (16 mg) and 5 (12 mg).
The 20% MeOH fraction was chromatographed on a Toyo-
pearl HW-40C column using aqueous MeOH (0–50%) to give
80 fractions. Fractions 24–60 were then sequentially chroma-
tographed on silica gel, Sephadex LH-20 and Toyopearl
HW-40C to afford 8 (24 mg) and 9 (15 mg). The 40% MeOH
fraction was chromatographed repeatedly on a Toyopearl
HW-40C column using MeOH or aqueous MeOH to yield
10 (8 mg).3.4. Identiﬁcation
Compound 1: White amorphous powder; mp 246–248 1C; ½a20D
36.7 (c 0.18, CHCl3); CD (MeOH) 223 (pos.), 248 (neg.), 285
(pos.); UV (MeOH) lmax nm (log e) 207 (3.48), 280 (4.16); IR
(KBr) umax cm
1 3338, 2927, 2856, 2723, 1674, 1530, 1209,
1105, 1064; HR-ESI-MS [MþNa]þ m/z 561.1945 (calcd. for
C26H34O12Na, 561.1947); NMR data are shown in Table 1.
Compounds 2–3: The 1H NMR and 13C NMR spectra
(measured at 40 1C) were consistent with those in the litera-
ture5 for amentoﬂavone (2) and hinokiﬂavone (3).
Compound 4: C27H30O14, yellow powder; ESI-MS m/z 579
[MþH]þ; 1H NMR (400 MHz, CD3OD) d 7.88 (2H, d,
J¼8.8 Hz, H-20,60), 6.92 (2H, d, J¼8.8 Hz, H-30, 50), 6.79
(1H, d, J¼2.1Hz, H-8), 6.67 (1H, s, H-3), 6.45 (1H, d,
J¼2.1 Hz, H-6), 5.28 (1 H, br s, H-rha1000), 5.19 (1H, d,
J¼7.6 Hz, H-glc100), 3.34-3.94 (10H, m, H-glc200-600, H-
rha2000-5000), 1.32 (3H, d, J¼6.2 Hz, H-rha6000); 13C NMR
(100 MHz, CD3OD) d 184.1 (C-4), 164.4 (C-2), 163.0 (C-7),
161.2 (C-5, 40), 159.0 (C-9), 129.7 (C-20, 60), 123.6 (C-10), 117.1
(C-30, 50), 104.1 (C-10), 102.5 (C-3), 102.5 (C-rha1000), 101.0 (C-
glc100), 99.8 (C-6), 95.9 (C-8), 79.1 (C-glc200), 79.0 (C-glc300),
78.3 (C-glc500), 73.9 (C-rha4000), 72.2 (C-rha2000), 72.1 (C-rha3000),
71.4 (C-glc400), 70.0 (C-rha5000), 62.4 (C-glc600), 18.2 (C-rha6000)6.
Compound 5: C21H20O10, yellow powder; ESI-MS m/z 433
[MþH]þ; 1H NMR (400 MHz, DMSO-d6) d 13.17 (1H, s,
5-OH), 10.85 (1H, br s, 7-OH), 10.36 (1H, br s, 40-OH), 8.03
(2H, d, J¼8.7 Hz), 6.89 (2H, d, J¼8.7 Hz), 6.79 (1H, s, H-3),
6.27 (1H, s, H-6), 4.68 (1H, d, J¼9.9 Hz, H-glc100); 13C NMR
(100 MHz, DMSO-d6) d 182.3 (C-4), 164.1 (C-2), 162.7 (C-7),
161.3 (C-40), 160.6 (C-9), 156.2 (C-5), 129.1 (C-20, 60), 121.8
(C-10), 116.0 (C-30, 50),104.8 (C-8), 104.2 (C-10), 102.6 (C-3),
98.3 (C-6), 82.0 (C-500), 78.8 (C-100), 73.5 (C-200), 71.0 (C-300),
70.7 (C-400), 61.4 (C-600)7.
Compound 6: C10H13N5O4, white tabular crystals (DMSO-
d6); ESI-MS m/z 268 [MþH]þ; 1H NMR (400 MHz, DMSO-
d6) d 8.36 (1H, s, H-2), 8.14 (1H, s, H-8), 5.89 (1H, d,
Compounds from Selaginella moellendorfﬁi Hieron 39J¼6.2 Hz, H-10), 5.47 (1H, s, 20-OH), 5.44 (1H, s, 50-OH), 5.21
(1H, s, 30-OH), 4.64 (1H, m, H-20), 4.16 (1H, m, H-30), 3.97 (1H,
m, H-40), 3.66 (1H, dd, J¼3.8, 12.0 Hz, H-50a), 3.55 (1H, dd,
J¼3.8, 12.0 Hz, H-50b); 13C NMR (100MHz, DMSO-d6) d: 156.4
(C-6), 152.6 (C-2), 149.3 (C-4), 140.2 (C-8), 119.6 (C-5), 88.1
(C-10), 86.1(C-40), 73.6 (C-20), 70.9 (C-30), 61.9(C-50)8.
Compound 7: C9H12N2O6, white powder; ESI-MS m/z 245
[MþH]þ; 1H NMR (400 MHz, CD3OD) d 8.00 (1 H, d,
J¼8.0 Hz, H-5), 5.90 (1H, d, J¼4.5 Hz, H-10), 5.69 (1H, d,
J¼8.0 Hz, H-6), 4.17 (1H, m, H-30), 4.15 (1H, m, H-20), 3.99
(1H, m, H-40), 3.85 (1H, dd, J¼2.6, 12.2 Hz, H-50a), 3.74 (1H,
dd, J¼2.6, 12.2 Hz, H-50b); 13C NMR (100 MHz, CD3OD) d
167.3 (C-4), 152.5 (C-2), 142.7 (C-5), 102.6 (C-6), 90.7 (C-10),
86.4 (C-40), 75.7 (C-30), 71.3 (C-20), 62.0 (C-50)9.
Compound 8: C12H12N2O2, pale yellow powder; EI-MS
m/z 216 [M]þ; 1H NMR (400 MHz, CD3OD) d 7.38 (1H, d,
J¼7.9 Hz, H-8), 7.23 (1H, d, J¼7.9 Hz, H-5), 7.03 (1H, t,
J¼7.9 Hz, H-6), 6.94 (1H, t, J¼7.9 Hz, H-7), 4.07 (2H, s,
H-1), 3.51 (1H, m, H-3), 3.15 (1H, ddd, J¼11.0, 8.0, 1.6 Hz,
H-4a), 2.80 (1H, dd, J¼11.0, 8.0 Hz, H-4b); 13C NMR
(100 MHz, CD3OD) d 179.6 (-COOH), 138.0 (C-9a), 132.4
(C-8a), 128.6 (C-5a), 122.0 (C-7), 119.6 (C-6), 118.5 (C-5),
111.7 (C-8), 108.6 (C-4a), 59.9 (C-3), 43.0 (C-1), 26.4 (C-4)10.
Compound 9: C8H8O4, white powder; EI-MS m/z 168 [M]
þ;
1H NMR (400 MHz, CD3OD) d 7.57 (1H, d, J¼1.8 Hz, H-2),
7.46 (1H, dd, J¼8.1, 1.8 Hz, H-6), 6.73 (1H, d, J¼8.1 Hz,
H-5), 3.87 (3H, s, –OCH3);
13C NMR (100 MHz, CD3OD)
d 170.6 (C-7), 151.8 (C-3), 148.1 (C-4), 125.0 (C-1), 124.2
(C-6), 115.1 (C-2), 114.0 (C-5), 56.3 (–OCH3)
11.
Compound 10: C20H24O6, white powder; EI-MS m/z 360 [M]
þ;
1H NMR (400 MHz, CD3OD) d 6.89 (1H, d, J¼1.8 Hz, H-2),
6.79 (1H, d, J¼1.8 Hz, H-20), 6.76 (1H, d, J¼7.8 Hz, H-50), 6.75
(1H, dd, J¼1.8, 7.8 Hz, H-6), 6.69 (1H, d, J¼7.8 Hz, H-5), 6.64
(1H, dd, J¼1.8, 7.8 Hz, H-60), 4.73 (1H, d, J¼7.0 Hz, H-7), 3.96
(1H, dd, J¼6.4, 8.3 Hz, H-90a), 3.84 (3H, s, –OCH3), 3.82 (3H, s,
–OCH3), 3.80 (1H, m, H-9a), 3.72 (1H, dd, J¼5.9, 8.3 Hz,
H-90b), 3.61 (1H, m, H-9b), 2.94 (1H, dd, J¼4.7, 13.3 Hz, H-
70a), 2.73 (1H, m, H-80), 2.48 (1H, dd, J¼11.5, 13.5 Hz, H-70b),
2.37 (1H, q, J¼7.2, 14.4 Hz, H-8); 13C NMR (100 MHz,
CD3OD) d 149.0 (C-3, 30), 147.2 (C-4), 145.8 (C-40), 135.6
(C-1), 133.5 (C-10), 122.2 (C-60), 119.8 (C-6), 116.2 (C-5), 116.0
(C-50), 113.3 (C-20), 110.6 (C-2), 84.0 (C-7), 73.5 (C-90), 60.4 (C-
9), 56.3 (–OCH3 2), 54.1 (C-8), 43.9 (C-80), 33.6 (C-70)12.
3.5. Acid hydrolysis of compound 1
Compound 1 (10 mg) was reﬂuxed with 4 mol/L HCl for 2 h
and then extracted with EtOAc. The aqueous layer wasadjusted to pH 6 with NaHCO3 and then reduced in volume.
The sugar in the aqueous layer was conﬁrmed as D-glucose
by comparison with an authentic sample on TLC (BuOH–
AcOH–H2O, 4:1:5 upper layer, D-glucose Rf 0.13, spray with
a-naphthol-sulfuric acid). The EtOAc layer was evaporated to
give the aglycone 1a (a new compound) characterized by
NMR as follows: 1H NMR (400 MHz, CD3OD) d 7.55 (1H, d,
J¼2.0 Hz, H-60), 7.46 (1H, d, J¼2.0 Hz, H-20), 6.32 (2H, s,
H-2,6), 3.98 (1H, m, H-8), 3.86 (1H, m, H-9a), 3.85 (3H, s,
–OCH3), 3.74 (1H, m, H-9b), 3.72 (6H, s, –OCH3), 3.01 (1H,
dd, J¼13.8, 6.0 Hz, H-7a), 2.81 (1H, dd, J¼13.8, 6.0 Hz,
H-7b), 2.55 (3H, s, –CH3);
13C NMR (100 MHz, CD3OD)
d 134.0 (C-1), 107.3 (C-2, 6), 148.4 (C-3, 5), 132.2 (C-4), 39.8
(C-7), 43.5 (C-8), 62.5 (C-9), 134.7 (C-10), 110.6 (C-20), 153.4
(C-30), 149.7 (C-40), 139.3 (C-50), 122.2 (C-60), 199.6 (C-70),
26.8 (C-80).References
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